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Abstract
Innate immunity recognizes bacterial molecules bearing pathogen-associated molecular patterns to launch inflammatory
responses leading to the activation of adaptive immunity. However, the lipopolysaccharide (LPS) of the gram-negative
bacterium Brucella lacks a marked pathogen-associated molecular pattern, and it has been postulated that this delays the
development of immunity, creating a gap that is critical for the bacterium to reach the intracellular replicative niche. We
found that a B. abortus mutant in the wadC gene displayed a disrupted LPS core while keeping both the LPS O-
polysaccharide and lipid A. In mice, the wadC mutant induced proinflammatory responses and was attenuated. In addition,
it was sensitive to killing by non-immune serum and bactericidal peptides and did not multiply in dendritic cells being
targeted to lysosomal compartments. In contrast to wild type B. abortus, the wadC mutant induced dendritic cell maturation
and secretion of pro-inflammatory cytokines. All these properties were reproduced by the wadC mutant purified LPS in a
TLR4-dependent manner. Moreover, the core-mutated LPS displayed an increased binding to MD-2, the TLR4 co-receptor
leading to subsequent increase in intracellular signaling. Here we show that Brucella escapes recognition in early stages of
infection by expressing a shield against recognition by innate immunity in its LPS core and identify a novel virulence
mechanism in intracellular pathogenic gram-negative bacteria. These results also encourage for an improvement in the
generation of novel bacterial vaccines.
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Introduction
Innate immunity plays a fundamental role in the defense against
microorganisms. In addition to the passive action of physical and
physicochemical barriers, the effectiveness of innate immunity
relies on pathogen recognition receptors that quickly perceive the
presence of invaders. Upon binding to microbial molecules
bearing pathogen-associated molecular patterns (PAMP), patho-
gen recognition receptors trigger a cascade of signals that include
the release of proinflammatory mediators, which in turn may
activate adaptive immunity. Cells like macrophages and dendritic
cells are equipped with a variety of pathogen recognition
receptors, which can be activated by bacterial PAMP such as
lipoproteins, glycolipids, peptidoglycan or DNA. However, some
bacteria are able to generate chronic infections by residing and
multiplying in these host cells. A relevant model of this kind of
pathogens is represented by the genus Brucella [1], a group of a-
Proteobacteria that have a great impact on animal and human health
worldwide, and whose virulence relies in part upon the failure of
pathogen recognition receptors to sense Brucella during the initial
stages of infection [2,3].
Brucella surface lipoproteins, ornithine lipids, flagellum-like
structures and the LPS do not bear a marked PAMP [2,3,4,5].
The most conspicuous PAMP bearing component of the surface of
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gram-negative bacteria is LPS, also known as endotoxin, a molecule
made of three sections: lipid A, core oligosaccharide and O-
polysaccharide (O-PS). Typically, LPS express a lipid A made of a
glucosamine disaccharide linked predominantly to C12 to C14 acyl
chains in ester, amide and acyl-oxyacyl bonds. This structure carries
a characteristic PAMP that is recognized by the TLR4-MD2
receptor-coreceptor complex, triggering potent proinflammatory
responses that may lead to endotoxic shock. Since Brucella lipid A (a
diaminoglucose disaccharide substituted with C16, C18, C28 and
other very long acyl chains [6]) structurally departs from the
canonical lipid A recognized by TLR4-MD2 [7], it is postulated to
play a key role in the stealthy behavior of this pathogen; indeed
Brucella LPS is poorly endotoxic [2,4,8,9]. In addition, the O-PS
characteristic of smooth brucellae like B. abortus, B. melitensis or B. suis
confers serum and complement resistance, a property not uncom-
mon in the O-PS of gram-negative pathogens, and also modulates
the entry into cells [1]. It is not known whether the LPS core sugar
structure of Brucella or any other gram-negative intracellular
pathogen has a direct role in intracellular virulence. Indeed,
mutants of smooth Brucella affected in the LPS core show different
degrees of attenuation, but these results cannot be unambiguously
interpreted because all core mutants described so far simultaneously
lack the O-chain. (i.e., are rough [R] mutants) and thus are
attenuated [10]. Here, we report that mutation of a hitherto
unidentified Brucella LPS core glycosyltransferase gene generates
attenuation without affecting the assembly and linkage of the O-PS
or the lipid A section. This attenuation is not caused by a
physiological defect associated with a damage of the envelope
properties but rather by the removal of a core section that hampers
recognition by complement, bactericidal peptides and TLR4-MD2,
thus representing a novel virulence mechanism.
Results
The B. abortus wadC glycosyltransferase gene is required
for the synthesis of a core section of smooth LPS
Up to now, only one Brucella core glycosyltransferase has been
identified [20]. Since LPS core structures are often conserved in
phylogenetically related organisms, we scanned the genomes of a-
Proteobacteria looking for orthologues of glycosyltransferases not
involved in O-PS synthesis. We identified B. abortus ORF
BAB1_1522 as encoding an orthologue (78% similarity) of the
Rhizobium leguminosarum core mannosyltransferase LpcC [11] and
named it wadC following accepted nomenclature [12]. We then
constructed a non-polar mutant (BaDwadC; Figure S1) of virulent B.
abortus 2308 NalR (Ba-parental) [9]. This mutant showed the same
dye and phage sensitivity pattern as the parental strain, and its
growth rate in bacteriological media was similarly unaffected
(Figure S2). In addition, the mutant reacted normally with
polyclonal antibodies to the O-PS and was smooth by the crystal
violet-exclusion and acriflavine tests, suggesting the presence of a
typical smooth LPS (S-LPS). Thus, for a better analysis of possible
LPS defects, we extracted the Ba-parental and BaDwadC LPSs using
the phenol-water protocol [13,14]. SDS-PAGE and Western-blots
with anti-O-PS and anti-core monoclonal antibodies showed that
the wild type LPS of the parental Ba-parental strain consisted of
both S and R fractions, as expected (Figure 1). However, the
BaDwadC LPS extracts showed a different migration pattern
suggesting a core defect. This peculiarity was confirmed by its lack
of reactivity of the anti-core monoclonal antibodies A68/24D08/
G09 (Figure 1), A68/24G12/A08 and A68/3F03/D5 (Figure S3).
The implication of wadC was confirmed by complementation with
plasmid pwadC (strain BaDwadC-comp) (Figure 1). In addition, the
lipids A of both Ba-parental and BaDwadC were dominated by
molecules carrying the very long chain fatty acids typical of Brucella
LPS, with minor and not consistent differences in the intensity of
some peaks as detected by mass spectrometry (Figure S4).
BaDwadC mutant is attenuated and induces
proinflammatory responses
BaDwadC displayed attenuation in mice (Figure 2A, left panel) with
an estimated spleen clearance time of 27 weeks (66 weeks for Ba-
parental). This attenuation, however, was less marked than that of a R
mutant (BaTn5::per) blocked in the synthesis of the only sugar (N-
formylperosamine) of the O-PS but with a complete core (Figure 2A,
left panel). BaDwadC induced a transient splenomegaly, in contrast to
the increasing splenomegaly observed in Ba-parental and the almost
absence of splenomegaly observed in the BaTn5::per inoculated mice
(Figure 2A, right panel). Complementation with plasmid pwadC
restored the replication, persistence and splenomegaly of BaDwadC
back to levels observed with the virulent Ba-parental (Figure S5).
Upon infection, BaDwadC triggered a more intense leukocyte
recruitment in the peritoneum and blood than Ba-parental (both
at 106 CFU/mouse) but less than the highly endotoxic Salmonella
enterica subspecies enterica serotype Typhimurium (S. Typhimur-
ium) (at 105 CFU/mouse) (Figure 2B). Concurrently, cytokine
levels (TNFa, IL-6, IL-12 p40/p70 and IL-10) measured in the
serum of BaDwadC infected mice were always higher than those
induced by the Ba-parental (Figure 2C).
BaDwadC mutant activates dendritic cells
We then investigated whether the attenuation and inflammatory
responses in mice were reproduced in target cells (dendritic cells
and macrophages). BaDwadC but not the complemented strain
BaDwadC-comp was killed in bone marrow-derived dendritic cells
(BMDC), although less rapidly than the virB9 type IV secretion
mutant used as a reference of attenuation (Figure 3, upper panel).
Moreover, in contrast to the Ba-parental strain, which segregated
at 24 h post-infection within the calnexin-positive endoplasmic
reticulum, the BaDwadC mutant-containing vacuoles colocalized
with the lysosomal LAMP-1 marker, indicating its failure to reach
the endoplasmic reticulum replication niche (Figure 3, lower
Author Summary
Brucellosis is one of the most extended bacterial zoonosis
in the world and an important cause of economic losses
and human suffering. The causative agents belong to the
genus Brucella, a group of highly infectious gram-negative
bacteria characterized by their ability to escape early
detection by innate immunity. This stealthy behavior
effectively delays the development of immunity, creating
a gap that is used by the bacterium to penetrate into a
variety of cells and to activate complementary virulence
mechanisms such as the type IV secretion system. By this
manner, the brucellae divert intracellular trafficking to
reach a safe multiplication niche and establish chronic
infections. Our results show that an inner section of the
Brucella LPS (a molecule that in most bacteria is detected
by innate immunity), effectively contributes to block
recognition by soluble molecules and cellular receptors
of the host innate immune system. Accordingly, a
mutation disrupting the inner but no other lipopolysac-
charide sections generates attenuation by impairing the
stealthiness characteristics of this pathogen. This is the first
Brucella mutant in which attenuation is specifically linked
to the bolstering of immunity against this pathogen.
Therefore, this new virulence mechanism opens the way
for the development of improved bacterial vaccines.
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panel). This attenuation was paralleled by an increased number of
Dendritic Cells Aggresome-Like Structures (DALIS) in infected
BMDC (Figure S6) indicating that dendritic cells were pro-
grammed to undergo a maturation process. Consequently,
secretion of IL-12 and TNF-a proinflammatory cytokines in
BaDwadC-infected BMDC at 24 h post-infection reached inter-
mediate levels between those of Ba-parental and S. Typhimurium
(Figure 4A, left panel). These observations were fully consistent
with the results obtained in mice. Interestingly, BaDwadC
multiplied as Ba-parental in bone marrow-derived macrophages
(BMDM; Figure 3, upper panel), Raw 264.7 macrophages or
HeLa cells (not shown) (see above).
BaDwadC mutant is sensitive to complement and
bactericidal peptides
In the absence of antibodies, Smooth Brucella cells are poor
activators of complement and are thus markedly resistant to the
bactericidal action of normal serum, a property that has been
attributed to the O-chain [15]. BaDwadC was more sensitive than
Ba-parental to the bactericidal action of serum and comparison with
the O-PS defective BaTn5::per mutant suggested that the LPS core
may be as important as the O-PS (Figure 5A). Brucellae are also
resistant to bactericidal polycationic peptides [16,17], a property
linked to a steric hindrance by the O-PS [17] as well as to the low
negative charge in the core and lipid A LPS sections, as assessed by
physicochemical methods [14]. We tested the sensitivity of
BaDwadC to two potent polycationic lipopeptides, polymyxin B
and colistin and demonstrated a greater sensitivity of BaDwadC
(Figure 5B) to these two agents. These results were confirmed using
synthetic poly-L-lysine and poly-L-ornithine (not shown).
BaDwadC LPS triggers dendritic cell maturation and
macrophage activation
We then carried out studies with purified LPSs. In experiments
performed to stimulate BMDC with purified LPS, the saturating
concentration for BaDwadC LPS was 10 mg/mL. This is one
hundred times more than the corresponding concentration of E.
coli LPS, a result that illustrates the importance of the expression of
an endotoxic lipid A for efficient cell activation. However, at
10 mg/mL, BaDwadC LPS induced the secretion of IL-12 and
TNF-a whereas Ba-parental LPS showed very low levels of
cytokine secretion (Figure 4A, right panel) also showing that the
presence of the core oligosaccharide in addition to the expression
of a long acyl-chain lipid A prevent Brucella LPS to show a marked
endotoxicity. These results closely matched those obtained in
infected BMDC (Figure 4A, left panel). Cytokine secretion was
TLR4-dependent since no pro-inflammatory cytokines were
detected in BMDC from TLR4 but not TLR2 (Figure 4B),
TLR6 (not shown) or TLR9 (Figure 4B) knockout mice stimulated
with BaDwadC LPS. Finally, BMDC showed an intermediate
matured phenotype as judged by the expression of CD40 and
CD86 co-stimulatory molecules and surface MHCII (Figure 4C)
that led to efficient cytokine secretion. Although BaDwadC
multiplied in macrophages (BMDM) (Figure 3, upper panel), its
core-defective purified LPS was capable of triggering a cytokine
response higher than that of the parental Ba-LPS (Figure S7B).
These results suggest that signaling by the mutated LPS during
BMDM infection and subsequent cell activation did not occur
early enough to prevent the mutant from reaching the replicative
niche.
BaDwadC LPS binds bactericidal peptides and serum
complement
Purified S-LPS forms supramolecular aggregates in which the
lipid A acyl chains display a characteristic and temperature-
dependent fluidity that increases upon the disturbance of the
aggregate caused by binding of bactericidal peptides and
complement molecules [18]. Accordingly, we measured this
parameter in the absence or the presence of serum or polymyxin
B. In the absence of any agent, the b«a transition that marks the
shift from crystalline to fluid phase took place in the 30 to 40uC
Figure 1. BaDwadC carries a partially defective LPS core oligosaccharide. Western blot analyses were performed with monoclonal
antibodies Cby-33H8 (O-polysaccharide C/Y epitope) and A68/24D08/G09 (core oligosaccharide) and SDS-proteinase K LPS extracts of Ba-parental,
BaDwadC and BaDwadC-compl (complemented mutant), and the SDS-PAGE electropherogram of LPS phenol-water extracts was silver stained.
doi:10.1371/journal.ppat.1002675.g001
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Figure 2. BaDwadC is attenuated in mice and induces transitory splenomegaly, local leukocyte recruitment and cytokine secretion.
(A), Left panel, infection kinetics in the spleens of mice intraperitoneally inoculated with 56104 Ba-parental, BaDwadC or 16108 BaTn5::per; right
panel, spleen weights. (B), Leukocyte and PMN levels in the peritoneum (left panel) and blood (right panel) of mice after intraperitoneal infection with
16106 Ba-parental, BaDwadC or 16105 S. Typhimurium SL1344. (C), TNF-a, IL-6, IL-10 and IL-12 p40/p70 levels in the sera of mice infected with Ba-
parental or BaDwadC. Each point is the mean6 standard deviation (n = 5). Differences between Ba-parental and BaDwadC are indicated with symbols
(*, p,0.05; #, p,0.001).
doi:10.1371/journal.ppat.1002675.g002
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range for B. abortus wild type LPS, with a transition temperature of
37uC (Figure 5C). The LPS of the BaDwadC mutant showed a very
different acyl chain fluidity profile with a transition temperature
between 45 and 55uC, and with a markedly more restricted fluidity
below transition temperature than the wild type LPS. Therefore,
the mutant LPS aggregates were in the crystalline phase at
physiological temperatures and, since the acyl-chain composition
of lipid A was not significantly affected (Figure S4), we attributed
this to the disruption induced in the core structure by mutation of
wadC. Despite this greater rigidity, the LPS aggregates of the
BaDwadC mutant were clearly affected by normal serum whereas
those of Ba-parental LPS were not (Figure 5C). Moreover, when
we measured the effect of polymyxin B on acyl chain fluidity, we
found a much less marked effect on wild type LPS than on the LPS
of the BaDwadC mutant (Figure 5B). These results show that the
core defect is uncovering the complement and polycations targets
(Kdo and lipid A phosphate groups) that exist in the innermost
sections of LPS [19], and are in agreement with the serum
complement and bactericidal peptide sensitivity of the mutant.
The core of B. abortus LPS interacts with MD-2
Most endotoxic effects of enterobacterial LPS depend on the
interaction with the TLR4 co-receptor MD-2, an event that
triggers a cascade of signals leading to the NF-kB-dependent
expression of immune response genes and a subsequent proin-
flammatory response [7]. Therefore, we explored the interaction
of BaDwadC LPS with MD-2 using a competitive ELISA using an
antibody that recognizes free- but not LPS-bound human MD-2
(hMD-2) [20]. Whereas Ba-parental LPS did not interact with
MD-2 in the range of concentrations tested, BaDwadC LPS was
capable of binding to MD2, although at concentrations higher
than the reference endotoxic Salmonella LPS (Figure 6A) or E. coli
LPS (not shown). These results were confirmed by testing the
displacement of bis-ANS from MD-2. Whereas Ba-parental LPS
did not cause displacement in the range of the concentrations
tested (1.25–10 mg/mL), BaDwadC displaced this probe from MD-
2. Consistent with the results of the competitive ELISA, the
interaction of the mutated LPS with MD-2 observed using this
protocol did not reach the Salmonella LPS levels (Figure S8).
Figure 3. BaDwadC is attenuated in BMDC. Upper panel, intracellular replication of Ba-parental, BaDwadC, BaDwadC-compl and virB mutant in
BMDC and BMDM. Each point is the mean 6 standard error of an experiment performed in triplicate, and the results representative of three
independent experiments. Differences between Ba-parental and BaDwadC are indicated with symbols (#, p,0.001). Lower panel, confocal imaging
of Ba-parental and BaDwadC carrying a GFP plasmid at 24 h post-infection (calnexin and LAMP-1 are in red).
doi:10.1371/journal.ppat.1002675.g003
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Figure 4. BaDwadC induces a cytokine release that is reproduced by purified LPS in a TLR-4 dependent fashion. (A), IL-12 p40/p70 and
TNF-a released by BMDC 24 h after infection (left panel) or stimulation with 10 mg/mL of Ba-parental or BaDwadC LPS, or with 100 ng/mL of E. coli
LPS (right panel) measured by ELISA; (B), IL-12 p40/p70 (left panel) and TNF-a (right panel) released by BMDC from wild-type (WT), TLR92/2 TLR42/
2 or TLR22/2 mice 24 h after stimulation with 10 mg/mL of Ba-parental or BaDwadC LPS, or with 100 ng/mL of E. coli LPS measured by ELISA; (C),
Surface expression of CD40, CD86 and MHCII in LPS-stimulated BMDC measured by flow cytometry. Each point is the mean 6 standard error (n = 3).
But for TLR42/2 mice differences between Ba-parental and BaDwadC or their corresponding LPS were statistically significant (p,0.001). Results are
representative of two independent experiments.
doi:10.1371/journal.ppat.1002675.g004
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Figure 5. BaDwadC shows increased sensitivity to normal serum and bactericidal peptides that relates to the LPS core defect. (A),
Survival of Ba-parental, BaDwadC and BaTn5::per after incubation in non-immune calf serum for 90 min. Each point is the mean 6 standard error of
an experiment performed in triplicate, and the results representative of five independent experiments (differences between Ba-parental and
BaDwadC are indicated as #, p,0.001). (B), minimal inhibitory concentrations (MIC) of polymyxin B (determined by the serial dilution method) and
colistin (determined by the E-test) (results representative of three independent experiments). (C), Crystalline to fluid (b«a) phase transition of the
hydrocarbon chains of Ba-parental LPS and BaDwadC LPS measured in the presence (filled circles) or absence (empty circles) of normal human serum
(red circles) or polymyxin B (black circles; LPS:PMB 1:0.1 molar ratio). The plots represent the position (wavenumber) of the peak of the symmetric
stretching vibration of the methylene groups ns(CH2) versus temperature. Tc, transition temperature (results are representative of three independent
experiments).
doi:10.1371/journal.ppat.1002675.g005
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Interestingly, the LPS of Ochrobactrum anthropi (which carries a
Brucella-type lipid A but differs markedly in the core structure
[8,14]) showed a higher binding to MD2 than either the mutant or
the wild-type B. abortus LPS (Figure S9). Moreover, the percentage
of BMDC showing NF-kB translocation to the nucleus (Figure
S10) after 1 h of stimulation with BaDwadC LPS was clearly above
that of Ba-parental LPS (Figure 6B). Clearly, both sets of results
are in agreement with the cytokine profiles observed in mice and
target cells. In addition, since activation of the mTOR pathway
has been implicated in dendritic cell maturation and cytokine
production, we determined the phosphorylation of S6, one of the
downstream elements of this pathway [21]. When BaDwadC LPS
was compared to Ba-parental LPS, the former induced an earlier,
more intense and more sustained S6 phosphorylation (Figure 6C)
as detected from 30 min up to 6 h of LPS stimulation.
All this evidence suggests that the core of B. abortus LPS
negatively modulates recognition by MD-2/TLR4 and the
subsequent intracellular signaling leading to pro-inflammatory
response and dendritic cell maturation. In support of this
interpretation, the TLR4 dysfunction did not affect the multipli-
cation of the wild type but allowed a better replication of the
mutant in the spleens of mice (Figure S11). The replication of the
wadC mutant in TLR42/2 did not reach the levels of the wild
type, consistent with the existence of additional factors causing
attenuation such as the complement and polycation sensitivity
observed in vitro.
Discussion
We have identified a B. abortus LPS gene (wadC) whose
disruption does not result in the loss of the O-PS but in an altered
core, which is in contrast to all Brucella LPS genes described
[10,22,23,24]. This allowed us to discriminate the role of the LPS
core oligosaccharide from that of the O-polysaccharide in Brucella
Figure 6. BaDwadC LPS binds to MD-2 and increases NF-kB translocation and S6 phosphorylation. (A) LPS binding to hMD-2. After
incubation of 0.75 mM hMD-2 with increasing LPS concentrations, the fraction of hMD-2 not bound to LPS was detected with free-hMD-2 specific
antibody 9B4 by ELISA (results are representative of three independent experiments run in triplicate; differences between Ba-parental and BaDwadC
are indicated as *, p,0.05 or #, p,0.001) (B) NF-kB translocation to the nucleus. BMDC were stimulated for 1 h with media, E. coli LPS (100 ng/mL),
Ba-parental LPS (10 mg/mL) or BaDwadC LPS (10 mg/mL), cells fixed in 3% paraformaldehyde at 37uC for 15 min, immunostained for CD11c and
MHCII, and the % of cells showing nuclear translocation of the NF-kB subunit p65/RelA recorded (results are representative of three independent
experiments run in triplicate; differences between Ba-parental and BaDwadC are indicated as #, p,0.001). (C) S6 phosphorylation. BMDC were
stimulated for 30 min, 1, 4, or 6 h with (left to right) media, E. coli LPS (100 ng/mL), Ba-parental LPS (100 ng/mL), Ba-parental LPS (10 mg/mL) or
BaDwadC LPS (10 mg/mL). Cell lysates (30 mg protein) were analyzed by Western blot with a polyclonal antibody against S6-P or an anti-actin
antibody as control.
doi:10.1371/journal.ppat.1002675.g006
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virulence. The wadC LPS core mutant induced a strong proin-
flammatory response and was attenuated in mice and in dendritic
cells. These properties were reproduced by the purified wadC mutant
LPS but not by the wild type Ba-parental LPS. Activation was
TLR4-dependent and the core-mutated LPS displayed increased
binding to MD-2, the TLR4 co-receptor, which paralleled an
increased intracellular signaling. This is the first description of an
LPS core hampering complement activation, cationic peptide
binding and detection by TLR4-MD-2. Therefore, B. abortus LPS
core acts as a shield against innate immunity recognition and
represents a novel virulence-related mechanism. Studies in progress
with the B. melitensis, B. suis and B. ovis mutants in the wadC
orthologues confirm that this is a general mechanism of this group of
bacteria. Indeed, all our results also provide experimental proof that
the stealthy behavior of this pathogen towards innate immunity is
essential for its virulence, as proposed before [2,8].
Consistent with the key role of dendritic cells in brucellosis
[25,26,27], the attenuation and proinflammatory responses of the
wadC mutant in mice were reproduced in BMDC. It is noteworthy
that the attenuation was not observed in macrophages, and this
could be attributed to functional differences between these two
types of cells in the ability to process and present antigens.
Nevertheless, the results obtained in mice showed that the
observations made in dendritic cells are more relevant for the
course of the infection than those in macrophages in vitro.
Interference with dendritic cell maturation is a strategy that
prevents the development of efficient immunity and there are
several examples of intracellular pathogens that target dendritic
cells. Mycobacterium tuberculosis interferes with TLR signaling in
dendritic cells blocking their maturation and IL-12 generation and
directing the immunoresponse towards IL-10 production [28]. S.
Typhimurium, on the other hand, does not block maturation but
prevents MHC II antigen presentation in some subtypes of
dendritic cells [29,30]. Francisella tularensis, another gram-negative
pathogen that does not block dendritic cell maturation, seems to
be capable of multiplying in these cells and to inhibit the secretion
of pro-inflammatory cytokines [31]. However, only B. abortus, B.
melitensis and B. suis, the three classical smooth Brucella spp., have
been reported to be simultaneously able to multiply in dendritic
cells and to prevent their maturation, thereby thwarting the
efficient presentation of proteins in either the MHC I or MHC II
context [27]. The properties that enable the brucellae to display
these abilities are beginning to be understood. TLR2, TLR4 and
TLR9 seem to be the most important TLRs in dendritic cells, and
they recognize lipoproteins, LPS and CpG DNA, respectively.
Salcedo et al. [27] have recently shown that protein Btp1 of B.
abortus interferes with the TLR2 signaling pathway and down
modulates dendritic cell activation. Billard et al. [26] found that
the response of dendritic cells derived from peripheral blood
monocytes to wild type B. abortus LPS was low as compared to that
obtained with E. coli LPS. Our results extend these observations
and demonstrate the connection between the LPS core oligosac-
charide and the ability of B. abortus to thrive in dendritic cells and
to circumvent their maturation.
Chemical analyses of the B. abortus LPS core reveal the presence
of Kdo, glucosamine, glucose, mannose and quinovosamine [6].
Our results suggest that these sugars must be arranged in such a
way that some of them probably play no role in the section linking
the O-PS, as predicted before by studies with monoclonal
antibodies [23] and on the inability of polymyxin B to neutralize
the charge of B. abortus LPS [14]. Moreover, we have identified a
second glycosyltransferase gene (wadB) that, upon disruption,
generates an LPS phenotype close to the one described here for
BaDwadC. These genetic data indicate that at least two core sugars
must be arranged in a structure whose damage does not affect the
link to the O-PS. Research in progress shows the existence of a
mannose containing branch in the Brucella LPS core. WadC is a
putative mannosyltransferase and it seems likely that it could be
involved in the transfer of a mannose unit to such a branch. It is
tempting to speculate that such a structure hinders the access to
the Kdo and lipid A phosphates targeted by bactericidal peptides
as well as complement C1q [19], and could thus account for the
results of the transition measurements performed in the presence
of PMB and serum. We also propose that the full core structure is
one of the factors contributing to a defective MD-2 recognition,
the other one being the peculiar acyl chain composition of Brucella
lipid A. Two not mutually exclusive hypotheses could account for
the role of the complete core. Its absence in the mutant could favor
the dissociation of individual molecules from aggregates and make
them more readily available for binding to MD2, and the anionic
molecules and Kdo in the inner sections could be more accessible
for binding to MD2. In addition, it is known that C12-C14
hexaacylated lipids A like that of E. coli interact with a large
hydrophobic groove in MD-2, with five acyl chains deep inside,
the remaining chain in a hydrophobic interaction with TLR4 and
the bisphosphorylated glucosamine disaccharide tilted outwards
[7]. Therefore, the lipid A phosphate groups contribute to receptor
multimerization by interacting with positively charged residues in
TLR4 and MD-2 [7]. Previously, we proposed that the very long
chain fatty acids in Brucella lipid A are critical in preventing
effective recognition by TLR4-MD-2 [32] and here we show that
the interaction of both the wild type and the BaDwadC LPS with
MD-2 is significantly reduced as compared to that of Salmonella
LPS. This suggests that the MD-2 hydrophobic pocket does not
allow for efficient interaction with the bulky lipid A of Brucella.
Moreover, removal of part of the B. abortus LPS core increases the
binding to MD-2 indicating that interaction is hampered by
virulent B. abortus intact core. Since O. anthropi and B. abortus LPS
have similar a lipid A but a markedly different core structure
[8,14], the results obtained with the former in the MD2 assay also
suggest that core structures are important. The work in progress
on the structure of the B. abortus LPS core shows that the O-PS
stems from a few sugars linked to Kdo I, suggesting Kdo II as the
section linked to the sugar(s) removed by the wadC mutation.
Thus, these sugars should be close to the negatively charged
groups in the lipid A backbone and Kdo and could hinder cationic
peptide, C1q and MD-2 interactions. This structure may not be
unique to B. abortus. In fact, wadC homologues are found not only
in the genomes of all Brucella species but also in Bartonella spp.,
suggesting structures acting as shields against innate immunity
recognition.
Finally, current classical smooth brucellosis vaccines (B. abortus
S19 and B. melitensis Rev 1) are doubtlessly useful tools in animal
vaccination and, therefore, in the eradication of this zoonotic
disease, but do not afford 100% protection in the natural host.
Hence, their successful use requires complementary measures
(tagging and control of animal movement, efficient veterinary
services, repeated animal testing) that make brucellosis eradication
a cumbersome and long process [33]. We found that the cytokine
profile, with IL-12 being released in large amounts, the transitory
splenomegaly and the eventual clearance of BaDwadC could make
mutation of wadC a tool to improve existing or future vaccines.
Materials and Methods
Ethics
Animal experimentation was conducted in strict accordance
with good animal practice as defined by the French animal welfare
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bodies (Law 87–848 dated 19 October 1987 modified by Decree
2001-464 and Decree 2001-131 relative to European Convention,
EEC Directive 86/609). All animal work was approved by the
Direction De´partmentale des Services Ve´te´rinaires des Bouches du
Rhoˆnes (authorization number 13.118).
All animals were handled and sacrificed according to the
approval and guidelines established by the ‘‘Comite´ Institucional
para el Cuido y Uso de los Animales’’ of the Universidad de Costa
Rica, and in agreement with the corresponding law ‘‘Ley de
Bienestar de los Animales No 7451’’ of Costa Rica (http://www.
micit.go.cr/index.php/docman/doc_details/101-ley-no-7451-leyde-
bienestar-de-los-animales.html).
Mice (Charles River, Elbeuf, France) were accommodated in
the animal building of the CITA of Arago´n (ID registration
number ES-502970012005) in cages with water and food ad
libitum and under biosafety containment conditions, for 2 weeks
before the start and all along the experiment. The animal handling
and procedures were in accordance with the current European
legislation (directive 86/609/EEC) supervised by the Animal
Welfare Committee of the institution (protocol numberR102/
2007).
Bacterial strains and growth conditions
The bacterial strains and plasmids used are listed in Table S1.
Moreover, the strain Salmonella enterica subespecies enterica serotype
typhimurium (abbreviated as S. Typhimurium) reference ATCC
SL1344, Salmonella abortus equi strain HL83 and E. coli strain
MG1655 were used as controls in some assays. Bacteria were
routinely grown in standard tryptic soy broth or agar either plain
or supplemented with kanamycin at 50 mg/mL, or/and nalidixic
acid at 25 mg/mL, or/and 5% sucrose. All strains were stored in
skim milk at 280uC.
DNA manipulations
Plasmid and chromosomal DNA were extracted with Qiaprep
spin Miniprep (Qiagen GmbH, Hilden, Germany), and Ultraclean
Microbial DNA Isolation kit (Mo Bio Laboratories) respectively.
When needed, DNA was purified from agarose gels using Qiack
Gel extraction kit (Qiagen) and sequenced by the Servicio de
Secuenciacio´n de CIMA (Centro de Investigacio´n Me´dica
Aplicada, Pamplona, Spain). Primers were synthesized by
Sigma-Genosys Ltd. (Haverhill, United Kingdom). Searches for
DNA and protein homologies were carried out using the NCBI
(National Center for Biotechnology Information; http://www.
ncbi.nlm.nih.gov) and the EMBL-European Bioinformatics Insti-
tute server (http://www.ebi.ac.UK/ebi_home.html). In addition,
sequence data were obtained from The Institute for Genomic
Research website at http://www.tigr.org. Genomic sequences of
B. melitensis, B. abortus and B. suis were analyzed using the database
of the URBM bioinformatic group (http://urbm-cluster.urbm.
fundp.ac.be/,apage).
Construction of the Ba-parental wadC non polar mutant
(BaDwadC)
In-frame deletion mutant BaDwadC was constructed by PCR
overlap using genomic DNA of Ba-parental as DNA template
(Figure S1). Primers were designed based on the available
sequence of the corresponding genes in B. abortus 2308. For the
construction of the wadC mutant, we first generated two PCR
fragments: oligonucleotides wadC-F1 (59-CTGGCGTCAG-
CAATCAGAG-39) and wadC-R2 (59- GTGCAACGACCT-
CAACTTCC-39) were used to amplified a 476-bp fragment
including codons 1 to 16 of the wadC ORF, as well as 424 bp
upstream of the wadC start codon, and oligonucleotides wadC-F3
(59-GGAAGTTGAGGTCGTTGCACACGCCATC GAACCT-
TATCTG-39) and wadC-R4 (59-CGGCTATCGTGCGATTCT-
39) were used to amplify a 453-bp fragment including codons 308
to 354 of the wadC ORF and 320-bp downstream of the wadC stop
codon (see S-1). Both fragments were ligated by overlapping PCR
using oligonucleotides wadC-F1 and wadC-R4 for amplification,
and the complementary regions between wadC-R2 and wadC-F3
for overlapping. The resulting fragment, containing the wadC
deletion allele, was cloned into pCR2.1 (Invitrogen), to generate
plasmid pRCI-23, sequenced to ensure the maintenance of the
reading frame, and subsequently subcloned into the BamHI and
the XbaI sites of the suicide plasmid pJQK. The resulting mutator
plasmid (pRCI-26) was introduced in Ba-parental by conjugation.
The first recombination (integration of the suicide vector in the
chromosome) was selected by Nal and Kan resistance, and the
second recombination (excision of the mutator plasmid leading to
construction of the mutant by allelic exchange), was selected by
Nal and sucrose resistance and Kan sensitivity. The resulting
colonies were screened by PCR with primers wadC-F1 and wadC-
R4 which amplify a fragment of 929 bp in the mutant and a
fragment of 1805 bp in the parental strain. The mutation
generated results in the loss of the 82% of the wadC ORF, and
the mutant strain was called BaDwadC.
Complementation of BaDwadC
Taking into account that the WadC sequences of B. melitensis
and B. abortus are identical, we used the B. melitensis ORFeome
constructed with the Gateway cloning Technology (Invitrogen) for
complementation [34]. The clone carrying B. melitensis wadC was
extracted, and the DNA containing the corresponding ORF was
subcloned in pRH001 [35] to produce plasmid pwadC. To
complement the wadC mutation, plasmid pwadC was introduced
into the BaDwadC mutant by mating with E. coli S17-1 and the
conjugants harboring pwadC (designated as BaDwadC-comp) were
selected by plating the mating mixture onto TSA-Nal-Kan plates
which were incubated at 37uC for 3 days.
Virulence assay in mice
Seven-week-old female BALB/c mice (Charles River, Elbeuf,
France) were kept in cages with water and food ad libitum and
accommodated under biosafety containment conditions 2 weeks
before the start of the experiments. Inocula were prepared in
sterile 10 mM PBS (pH 6.85). For each strain, 30 mice were
inoculated intraperitoneally with 0.1 mL of inoculum containing
5.86104 (Ba-parental) or 4.96104 (BaDwadC) CFU/mouse and
the number of CFU in spleens (n = 5) was determined at 1, 2, 4, 6,
8, and 12 weeks after inoculation. BaTn5::per was used as control
of representative R mutant with complete LPS-core, at inoculation
dose of 16108 CFU intraperitoneally and viable counts in spleens
at 1, 2, 3, 6 and 9 weeks post-infection. An additional experiment
was performed under the same conditions but including BaDwadC-
comp and the number of CFU in spleens was determined 8 weeks
after inoculation. The identity of the spleen isolates was confirmed
by PCR at each time-point during the infection process. The
individual data were normalized by logarithmic transformation,
and the mean and standard deviation (SD) of log10 CFU/spleen
were calculated.
Leukocyte counts
BALB/c mice from 20 and 24 g were intraperitoneally injected
with 106 CFU of Ba-parental, 105 of S. Typhimurium or 0.1 mL
pyrogen-free sterile PBS. Blood was collected from the retro-
orbital sinus and subjected to analysis. Alternatively, 5 mL of ice
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cold PBS were injected in the peritoneal cavity of killed the mice,
and the fluids collected with a syringe (from 3.8 to 4.5 mL) from
exposed peritoneal cavity. Then fluids were centrifuged and the
peritoneal cells resuspended in 0.2 mL of PBS and counted in
Neubauer chambers. Giemsa-Wright staining smears were per-
formed to distinguish between leukocytes.
Intracellular multiplication
Bone marrow cells were isolated from femurs of 7–8-week-old
C57Bl/6 female, TLR22/2, TLR42/2 or TLR92/2 [36,37]
mice and differentiated into either dendritic cells (BMDCs) or
macrophages (BMDMs) as described previously [38,39] in
presence of decomplemented fetal bovine serum. Infections were
performed by centrifuging the bacteria onto the differentiated cells
(4006g for 10 min at 4uC; bacteria: cells ratio of 20:1 for BMDCs
or 50:1 for BMDMs) followed by incubation at 37uC for either
15 min (BMDMs) or 30 min (BMDCs) under a 5% CO2
atmosphere. Cells were either extensively washed (BMDMs) or
gently washed (BMDCs) with medium to remove extracellular
bacteria and incubated in medium supplemented with 100 mg/mL
gentamicin for 1 h to kill extracellular bacteria. Thereafter, the
antibiotic concentration was decreased to 20 mg/mL. To monitor
Brucella intracellular survival, infected cells were lysed with 0.1%
(vol/vol) Triton X-100 in H2O (BMDCs) or after PBS washing
(BMDMs) and serial dilutions of lysates were rapidly plated onto
tryptic soy agar plates to enumerate CFU.
Cytokine measurement
The levels of TNF- a, IL-6, IL-10 and IL-12 p40/p70 were
estimated at different time points by enzyme-linked immunosor-
bent assays (ELISA) in the sera of BALB/c mice infected
intraperitoneally, and in the supernatants of BMDC or BMDM
at 24 hours after infection (see above) or after stimulation with
10 mg/mL of the appropriate LPS from different Brucella strains or
100 ng/mL from E. coli ATCC 35218 obtained by the phenol-
water procedure and purified further by the phenol-water-
deoxycholate method [40]. For the latter purpose, a stock of
1 mg/mL in pyrogen free sterile water was prepared, sonicated
briefly and sterilized by autoclaving. Prior to use, the stock was
heated at 56uC for 15 min and then cooled to room temperature.
Immunofluorescence assays
BMDCs were grown on glass coverslips and inoculated with
bacteria as described above or stimulated with the appropriate
LPS. At different times after inoculation (see Results), coverslips
were fixed with 3% paraformaldehyde pH 7.4 at 37uC for 15 min
and washed three times with PBS. Coverslips were processed for
immunofluorescence staining as previously described [39]. Briefly,
cells were permeabilized with 0.1% saponin and incubated with
primary antibodies. After several washes, the primary antibodies
were revealed with the appropriate secondary antibodies. The
primary antibodies used for immunofluorescence microscopy
were: cow anti-B. abortus; rat anti-mouse LAMP1 ID4B (Develop-
mental Studies Hybridoma Bank, National Institute of Child
Health and Human Development, University of Iowa); mouse anti
FK2 (Biomol); Moab anti-calnexin (kindly provided by Dr. D.
Williams, University of Toronto) and NF-kB subunit p65/RelA
(Santa Cruz). In all experiments, BMDCs were labeled using an
antibody against a conserved cytoplasmic epitope found on MHC-
II I-A ß subunits or MHC II [29] which does not produce
significant labeling with BMDMs. In addition, BMDCs were
labeled with an anti–CD11c antibody (Biolegend) confirming that
they are dendritic cells [27]. Samples were analyzed under a Leica
DMRBE epifluorescence microscope for quantitative analysis, or a
Zeiss LSM 510 laser scanning confocal microscope for image
acquisition. Images were then assembled using Adobe Photoshop
7.0. Quantifications were done by counting at least 300 cells in 3
independent experiments.
Immunoblotting
30 mg of cell lysates were subjected to SDS-PAGE and, after
transfer to nitrocellulose, the membrane was probed with a
polyclonal antibody against phospho-S6 (Cell Signaling Technol-
ogy) that detects phosphorylation on Ser235/236 or anti-actin
antibody. Blots were subjected to enhanced chemiluminescence
detection (ECL, PIERCE).
Flow cytometry
BMDCs treated with different types of LPS’s were collected and
stained immediately before fixation with paraformaldehyde.
Isotype controls were included as well as BMDCs treated with
the different secondary antibodies for control of autofluorescence.
Cells were always gated on CD11c and a minimum of 12,000
CD11c-positive events were obtained for analysis. A FACScalibur
cytometer (Beckton Dickinson) was used and data were analysed
using FlowJo software (Tree Star). Allophycocyanin (APC)
conjugated-anti-CD11c antibody (HL3) from Pharmigen was used
in all experiments along with either phycoerythrin (PE) conjugated
anti-CD86, anti-IA-IE (MHC class II) or fluorescein isothiocya-
nate (FITC) conjugated anti-CD40, all from BioLegend.
LPS extraction and characterization
Extraction of whole-cell LPS by SDS-proteinase K protocol was
performed as described previously [41]. In addition, LPS was
obtained by methanol precipitation of the phenol phase of a
phenol-water extract [13]. This fraction (10 mg/mL in 175 mM
NaCl, 0.05% NaN3, 0.1 M Tris-HCl [pH 7.0]) was then purified
by digestion with nucleases (50 mg/mL each of DNase-II type V,
and RNase-A [Sigma, St. Louis, Missouri, U.S.A.], 30 min at
37uC) and three times with proteinase K (50 mg/mL, 3 hours at
55uC), and ultracentrifuged (6 h, 100,0006 g). When we applied
this method to BaDwadC, we found that the supernatant of the
ultracentrifugation step contained the major fraction of the LPS.
The studies were performed with the major LPS fractions of each
bacteria. Free lipids (ornithine lipids and phospholipids) were then
removed by a fourfold extraction with chloroform-methanol. (2:1
[vol/vol]) [14].
LPS were analyzed in 15 or 18% polyacrylamide gels (37.5:1
acrylamide/methylene-bisacrylamide ratio) in Tris-HCl-glycine
and stained by the periodate-alkaline silver method [42]. For
Western blots, gels were electrotransferred onto nitrocellulose
sheets (Schleicher & Schuell GmbH, Dassel, Germany), blocked
with 3% skim milk in PBS with 0.05% Tween 20 overnight, and
washed with PBS–0.05% Tween 20. Immune sera were diluted in
this same buffer and, after incubation overnight at room
temperature, the membranes were washed again. Bound immu-
noglobulins were detected with peroxidase-conjugated goat anti-
mouse immunoglobulin (Nordic,Tilburg, Netherlands) and 4-
chloro-1-naphthol- H2O2. Monoclonal antibodies (Moabs) used in
this study were Cby-33H8 (Ingenasa, Madrid, Spain), which
recognizes the C/Y O-chain epitope, and A68/24D08/G09,
A68/24G12/A08, and A68/3F03/D5 which recognize core
epitopes [43]. The inner core LPS marker Kdo was determined
colorimetrically by the thiobarbituric acid method using pure Kdo
and deoxyribose as the standards, with the modifications described
previously [44]. Kdo contents were 1.6 and 2.4% for the wild type
and the mutated LPS, respectively.
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Lipid A analysis
Lipid A fractions were extracted using an ammonium hydrox-
ide/isobutyric acid method and subjected to negative ion matrix-
assisted laser desorption ionization time-of-flight (MALDI-TOF)
mass spectrometry analysis [45,46]. Briefly, lyophilized crude cells
(20 mg) were resuspended in 400 mL isobutyric acid/1M ammo-
nium hydroxide (5:3, v/v) and were incubated in a screw-cap test
tube at 100uC for 2 h, with occasional vortexing. Samples were
cooled in ice water and centrifuged (2,0006g for 15 min). The
supernatant was transferred to a new tube, diluted with an equal
volume of water, and lyophilized. The sample was then washed
twice with 400 mL methanol and centrifuged (2,0006g for
15 min). The insoluble lipid A was solubilized in 100 mL
chloroform/methanol/water (3:1.5:0.25, v/v/v). Analyses were
performed on a Bruker Autoflex II MALDI-TOF mass spectrom-
eter (Bruker Daltonics, Incorporated) in negative reflective mode
with delayed extraction. Each spectrum was an average of 300
shots. The ion-accelerating voltage was set at 20 kV. Dihydrox-
ybenzoic acid (Sigma Chemical Co., St.Louis, MO) was used as a
matrix. A few microliters of lipid A suspension (1 mg/mL) was
desalted with a few grains of ion-exchange resin (Dowex 50W-X8;
H+) in an Eppendorf tube. A 1 mL aliquot of the suspension (50–
100 mL) was deposited on the target and covered with the same
amount of the matrix suspended at 10 mg/mL in a 0.1 M solution
of citric acid. Different ratios between the samples and dihydrox-
ybenzoic acid were used when necessary. A peptide calibration
standard (Bruker Daltonics) was used to calibrate the MALDI-
TOF. Further calibration for lipid A analysis was performed
externally using lipid A extracted from E. coli strain MG1655
grown in LB at 37uC.
LPS binding to hMD-2
Binding of LPS to MD-2 was assayed by two different methods:
binding to hMD-2 by competitive ELISA and displacement of bis-
ANS (4,49-Dianilino-1,19-binaphthyl-5,59-disulfonic acid dipotas-
sium salt) from MD-2 by LPS. In both assays, LPS was sonicated
before use and subjected to three cycles of heating at 56uC
followed by cooling to 4uC.
The ELISA for determination of LPS binding to hMD-2 was
performed in 96-well plates (NUNC immunoplate F96 cert. Maxi-
sorp, Roskilde, Denmark).Chicken anti-hMD-2 (GenTel, Madi-
son, WI, U.S.A) (5 mg/mL) in 50 mM Na2CO3 (pH 9.6) was used
to coat the microtiter plate at 4uC overnight. Excess binding sites
were blocked with 1% BSA in PBS buffer (pH 7.2) for 1 h at room
temperature, and rinsed three times with the same buffer. During
the blocking step, hMD-2 (0.75 mM) was preincubated with 0 mM
to 8 mM LPS at 37uC and, as a negative control, LPS was also
preincubated in absence of hMD-2. This preincubated solutions
were added to the plate, which was then incubated for 1 h at
37uC. After rinsing, hMD-2 not bound to LPS was detected by
incubation with 0.1 mg/mL of mouse anti h-MD-2 (clone 9B4 e-
Bioscience San Diego, CA., U.S.A.) in PBS buffer at 37uC for 1 h,
followed by incubation with 0.1 mg/mL peroxidase-conjugated
goat anti-mouse IgG (Santa Cruz, CA., U.S.A.), also in PBS buffer
at 37uC for 1 h. After plate washing, ABTS (Sigma) was added,
the reaction was stopped with 1% SDS after 15 min, and the
absorbance at 420 nm measured using a Mithras LB940 apparatus
(Berthold Technologies). Salmonella abortus equi (strainHL83) LPS,
used as a control, was prepared by a phenol extraction procedure
and was kindly provided by Dr. Brandenburg (Forschungszentrum
Borstel, Germany).
Since the binding site of bis-ANS overlaps with the MD-2 binding
site of LPS we measured the displacement of the probe by the LPS
of Ba-parental and BaDwadC using Salmonella LPS as a control
[47].Binding of bis-ANS to hMD-2 was measured at 20uC using
excitation at 385 nm and measuring the emission fluorescence
spectra between 420 and 550 nm. Then, increasing amounts of LPS
were added to preincubated bis-ANS/hMD-2 complex (200 nM/
200 nM). The F0 value was the fluorescence intensity of bis-ANS/
hMD-2 complexes at 490 nm after 30 min of incubation (to reach
stable fluorescence).The FLPS value was the fluorescence at 490 nm
after LPS addition to the complex. Fluorescence was measured on
Perkin Elmer fluorimeter LS 55. Quartz glass cuvette (565 mm
optical path, Hellma Suprasil) was used and bis-ANS was obtained
from Sigma (St. Louis, Missouri, U.S.A.).
LPS-Complement and -polymyxin B interactions
determined by acyl-chain fluidity measurements
The transition of the acyl chains of LPS from a well-ordered
state (gel phase) to a fluid state (liquid crystalline phase) at a lipid-
specific temperature (Tc) was determined by Fourier transform
infrared spectroscopy. A specific vibrational band, the symmetric
stretching vibration of the methylene groups ns(CH2) around
2,850 cm21, was analyzed since its peak position is a measure of
the state of order (fluidity) of the acyl chains. Measurements were
performed in a Bruker IFS 55 apparatus (Bruker, Karlsruhe,
Germany) as described previously [48]. To ensure homogeneity,
LPS suspensions were prepared in 2.5 mM HEPES (pH 7.2) at
room temperature, incubated at 56uC for 15 min, stirred, and
cooled to 4uC. This heating/cooling step was repeated three times,
and the suspensions were stored at 4uC for several hours before
analysis. LPS suspensions (water content, 90%) were analyzed in
CaF2 cuvettes with 12.5-mm Teflon spacers, and for each
measurement, 50 interferograms were accumulated, Fourier
transformed, and converted to absorbance spectra. The measure-
ments were obtained in continuous heating scans (2uC/min)
between 10uC and 60uC. To test the effect of complement, the
experiments were performed in the presence of normal human
serum. The effect of polymyxin B was assessed similarly at
different LPS:polymyxin B molar ratios (see Results), and using an
average MW of 11800 for Ba-2308 LPS (determined by SDS-
PAGE with Yersinia enterocolitica O:8 LPS as a standard).
Sensitivity to brucellaphages, dyes, antibiotics and
polycationic bactericidal peptides
The minimal inhibitory concentrations (MIC) of polymyxin B,
poly-L-ornithine, poly-L-lysine, colistin, penicillin, doxycycline,
clarithromycin, erythromycin, rifampicin, basic fuchsin, safranine
and thionin was determined in Mu¨ller-Hinton medium by
standard procedures. Sensitivity to the S (Tb, Wb, Iz) and rough
(R/C) -specific brucellaphages was measured by testing the lysis of
bacteria exposed to serial 10-fold dilutions made from a routine
test dilution phage stock [49].
Sensitivity to the bactericidal action of non-immune
serum
Exponentially growing bacteria were adjusted to 104 CFU/mL
in saline and dispensed in triplicate in microtiter plates (45 mL per
well) containing fresh normal bovine serum (90 mL/well). After
90 min of incubation at 37uC, brain heart infusion broth was
dispensed (200 mL/well), mixed with the bacterial suspension and
100 mL was plated on TSA. Results were expressed as the
percentage of the average CFU with respect to the inoculum.
Statistical analysis
The Kolmogorov-Smirnov test was applied to assess the normal
distribution of data obtained in each experiment. Thereafter,
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means were statistically compared by an unpaired Student’s t test.
Kruskal-Wallis and Mann-Whitney tests were used for experi-
ments with non-normal data distribution. The StatviewGraphics
5.0 for Windows (SAS Institute Inc) statistical package was used in
all cases.
Supporting Information
Figure S1 BAB1_1522 (BaDwadC) and its upstream and
downstream regions. The DNA sequence is registered at
NCBI with accession number YP_414888.1 (Gene ID: 3788779).
Start and stop codons are in blue characters; grey characters
denote intergenic nucleotides; primers used for mutagenesis are in
bold characters; red and green characters mark amino acids
deleted and present in BaDwadC, respectively.
(TIF)
Figure S2 Representative growth curves of Ba-parental
and BaDwadC in TSB at 376C. (each point represents the
mean of triplicate samples; the experiment was repeated three
times with similar results).
(TIF)
Figure S3 BaDwadC carries a partially defective LPS
core oligosaccharide. Western blot analyses were performed
with monoclonal antibodies Cby-33H8 (O-polysaccharide C/Y
epitope) A68/24D08/G09, A68/24G12/A08 and A68/3F03/D5
(core oligosaccharide) and SDS-proteinase K LPS extracts of Ba-
parental, BaDwadC and BaDwadC-compl (complemented mutant).
(TIF)
Figure S4 MALDI-TOF analysis of lipid A. The table
summarizes the results obtained with several independent
preparations, and the figures below show representative spectra
(peak B is an uncharacterized molecular species).
(TIF)
Figure S5 Complementation with pwadC restores the
ability of BaDwadC to multiply in mice. Mice were
inoculated intraperitoneally with 56104 Ba-parental, BaDwadC
and BaDwadC-compl (complemented mutant). Number of CFU in
spleens was determined eight weeks after inoculation. Differences
between BaDwadC and Ba-parental or BaDwadC-compl were
statistically significant. (#, p,0.001).
(TIF)
Figure S6 BaDwadC induces DALIS in BMDC. (A),
Percentages of BMDCs infected with either Ba-parental, BaDwadC
or S. Typhimurium that contain DALIS. (B), representative
confocal images of BMDCs infected with Ba-parental GFP or
BaDwadC GFP (in green) labeled with Moabs to CD11c (in blue)
and FK2 (in red) 24 hours after infection.
(TIF)
Figure S7 BaDwadC LPS induces cytokine release in
BMDM. (A), Intracellular replication of Ba-parental, BaDwadC,
BaDwadC-compl and virB mutant in BMDM. (B), TNF-a (left
panel) and IL-12 p40/p70 (right panel) released by BMDM 24 h
after incubation with 10 mg/mL of Ba-parental or BaDwadC LPS,
or with 100 ng/mL of E. coli LPS as measured by ELISA.
(TIF)
Figure S8 LPS binding to MD-2 assessed by displace-
ment of bis-ANS. The bis-ANS/hMD2 complex (200 nM/
200 nM) was incubated for 30 min to reach stable fluorescence
(F0). Then, increasing amounts of the indicated LPSs were added
and fluorescence (FLPS) measured. Salmonella LPS was used as
control. The results shown are representative of three independent
experiments.
(TIF)
Figure S9 Ochrobactrum anthropi LPS binding to MD-2.
(A), After incubation of 0.75 mM hMD-2 with increasing LPS
concentrations, the fraction of hMD-2 not bound to LPS was
detected with free-hMD-2 specific antibody 9B4 by ELISA. (B),
MALDI-TOF analysis of Ochrobactrum anthropi lipid A.
(TIF)
Figure S10 Nuclear translocation of NF-kB subunit in
LPS-stimulated BMDC. Cells were stimulated for 1 h with cell
culture medium, E. coli LPS (100 ng/mL), Ba-parental LPS
(10 mg/mL) or BaDwadC LPS (10 mg/mL). Cells were stained with
CD11c (in blue) and MHCII (in green). The nuclear translocation
NF-kB subunit p65/ReiA (in red) was analyzed by confocal
microscopy.
(TIF)
Figure S11 Multiplication of Ba-parental or BaDwadC
in the spleens of TLR4 KO mice. Mice were intraperitoneally
inoculated with 16106 CFU of either Ba-parental or BaDwadC.
Ten weeks after infection the number of CFU per spleen were
determined.
(TIF)
Acknowledgments
We thank Ste´phane Me´resse for critically reading the manuscript.
Author Contributions
Conceived and designed the experiments: JPG IM EM RJ JAB MI.
Performed the experiments: RCA VAG EBC LPC CCD ECO AM MJG
KB EL KVB MMK. Analyzed the data: RCA VAG EBC LPC CCD ECO
AM MJG KB EL JPG IM EM RJ JAB MI KVB MMK. Contributed
reagents/materials/analysis tools: RCA VAG EBC LPC AM MJG KB EL.
Wrote the paper: JPG IM.
References
1. Gorvel JP, Moreno E (2002) Brucella intracellular life: from invasion to
intracellular replication. Vet Microbiol 90: 281–297.
2. Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzman-Verri C, Chaco´n-
Dı´az C, et al. (2007) Brucella abortus uses a stealthy strategy to avoid activation of
the innate immune system during the onset of infection. PLoS One 2: e631.
3. Martirosyan A, Moreno E, Gorvel JP (2011) An evolutionary strategy for a
stealthy intracellular Brucella pathogen. Immunol Rev 240: 211–234.
4. Lapaque N, Moriyo´n I, Moreno E, Gorvel JP (2005) Brucella lipopolysaccharide
acts as a virulence factor. Curr Opin Microbiol 8: 60–66.
5. Palacios-Chaves L, Conde-A´lvarez R, Gil-Ramı´rez Y, Zu´n˜iga-Ripa A, Bar-
quero-Calvo E, et al. (2011) Brucella abortus ornithine lipids are dispensable outer
membrane components devoid of a marked pathogen-associated molecular
pattern. PLoS One 6: e16030.
6. Iriarte M, Gonza´lez D, Delrue RM, Monreal D, Conde R, et al. (2004) Brucella
Lipopolysaccharide: Structure, Biosynthesis and Genetics. In: Lo´pez-Gon˜i I,
Moriyo´n I, eds. Brucella: Molecular and Cellular Biology. Wymondham, UK:
Horizon Bioscience. pp 159–192.
7. Park BS, Song DH, Kim HM, Choi BS, Lee H, et al. (2009) The structural basis
of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:
1191–1195.
8. Barquero-Calvo E, Conde-A´lvarez R, Chaco´n-Dı´az C, Quesada-Lobo L,
Martirosyan A, et al. (2009) The differential interaction of Brucella and
Ochrobactrum with innate immunity reveals traits related to the evolution of
stealthy pathogens. PLoS One 4: e5893.
9. Sola-Landa A, Pizarro-Cerda´ J, Grillo´ MJ, Moreno E, Moriyo´n I, et al. (1998) A
two-component regulatory system playing a critical role in plant pathogens and
endosymbionts is present in Brucella abortus and controls cell invasion and
virulence. Mol Microbiol 29: 125–138.
10. Gonza´lez D, Grillo´ MJ, de Miguel MJ, Ali T, Arce-Gorvel V, et al. (2008)
Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough
Brucella LPS Shields Against Innate Immunity
PLoS Pathogens | www.plospathogens.org 13 May 2012 | Volume 8 | Issue 5 | e1002675
mutants defective in core and O-polysaccharide synthesis and export. PLoS One
3: e2760.
11. Kadrmas JL, Allaway D, Studholme RE, Sullivan JT, Ronson CW, et al. (1998)
Cloning and overexpression of glycosyltransferases that generate the lipopoly-
saccharide core of Rhizobium leguminosarum. J Biol Chem 273: 26432–26440.
12. Reeves PR, Hobbs M, Valvano MA, Skurnik M, Whitfield C, et al. (1996)
Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol 4:
495–503.
13. Leong D, Dı´az R, Milner K, Rudbach J, Wilson JB (1970) Some structural and
biological properties of Brucella endotoxin. Infect Immun 1: 174–182.
14. Velasco J, Bengoechea JA, Brandenburg K, Lindner B, Seydel U, et al. (2000)
Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in
outer membrane permeability and cationic peptide resistance. Infect Immun 68:
3210–3218.
15. Eisenschenk FC, Houle JJ, Hoffmann EM (1999) Mechanism of serum resistance
among Brucella abortus isolates. Vet Microbiol 68: 235–244.
16. Freer E, Moreno E, Moriyo´n I, Pizarro-Cerda´ J, Weintraub A, et al. (1996)
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydropho-
bic probes and more sensitive to cationic peptides and EDTA than are their
native Brucella sp. counterparts. J Bacteriol 178: 5867–5876.
17. Martı´nez de Tejada G, Pizarro-Cerda J, Moreno E, Moriyo´n I (1995) The outer
membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect
Immun 63: 3054–3061.
18. Brandenburg K, David A, Howe J, Koch MH, Andra J, et al. (2005)
Temperature dependence of the binding of endotoxins to the polycationic
peptides polymyxin B and its nonapeptide. Biophys J 88: 1845–1858.
19. Moriyo´n I (2003) Against Gram-negative Bacteria: The LPS case. In: Gorvel JP,
ed. Intracellular Pathogens in Membrane Interactions and Vacuole Biogenesis
Landes Bioscience/Eurekah.com, Georgetown,Texas. pp 204–230.
20. Gradisar H, Keber MM, Pristovsek P, Jerala R (2007) MD-2 as the target of
curcumin in the inhibition of response to LPS. J Leukoc Biol 82: 968–974.
21. Delgoffe GM, Powell JD (2009) mTOR: taking cues from the immune
microenvironment. Immunology 127: 459–465.
22. Allen CA, Adams LG, Ficht TA (1998) Transposon-derived Brucella abortus rough
mutants are attenuated and exhibit reduced intracellular survival. Infect Immun
66: 1008–1016.
23. Monreal D, Grillo´ MJ, Gonza´lez D, Marı´n CM, de Miguel MJ, et al. (2003)
Characterization of Brucella abortus O-polysaccharide and core lipopolysaccha-
ride mutants and demonstration that a complete core is required for rough
vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse
model. Infect Immun 71: 3261–3271.
24. Ugalde JE, Czibener C, Feldman MF, Ugalde RA (2000) Identification and
characterization of the Brucella abortus phosphoglucomutase gene: role of
lipopolysaccharide in virulence and intracellular multiplication. Infect Immun
68: 5716–5723.
25. Billard E, Dornand J, Gross A (2007) Brucella suis prevent human dendritic cell
maturation and antigen presentation through the regulation of TNF-{alpha}
secretion. Infect Immun 75: 4980–4989.
26. Billard E, Dornand J, Gross A (2007) Interaction of Brucella suis and Brucella
abortus rough strains with human dendritic cells. Infect Immun 75: 5916–5923.
27. Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, et al. (2008) Brucella
control of dendritic cell maturation Is dependent on the TIR-containing protein
Btp1. PLoS Pathog 4: e21.
28. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vanden-
broucke-Grauls CM, et al. (2003) Mycobacteria target DC-SIGN to suppress
dendritic cell function. J Exp Med 197: 7–17.
29. Petrovska L, Aspinall RJ, Barber L, Clare S, Simmons CP, et al. (2004)
Salmonella enterica serovar Typhimurium interaction with dendritic cells:
impact of the sifA gene. Cell Microbiol 6: 1071–1084.
30. Svensson M, Johansson C, Wick MJ (2000) Salmonella enterica serovar
typhimurium-induced maturation of bone marrow-derived dendritic cells. Infect
Immun 68: 6311–6320.
31. Bosio CM, Dow SW (2005) Francisella tularensis induces aberrant activation of
pulmonary dendritic cells. J Immunol 175: 6792–6801.
32. Lapaque N, Takeuchi O, Corrales F, Akira S, Moriyo´n I, et al. (2006)
Differential inductions of TNF-alpha and IGTP, IIGP by structurally diverse
classic and non-classic lipopolysaccharides. Cell Microbiol 8: 401–413.
33. Moriyo´n I, Grillo´ MJ, Monreal D, Gonza´lez D, Marı´n C, et al. (2004) Rough
vaccines in animal brucellosis: structural and genetic basis and present status.
Vet Res 35: 1–38.
34. Dricot A, Rual JF, Lamesch P, Bertin N, Dupuy D, et al. (2004) Generation of
the Brucella melitensis ORFeome version 1.1. Genome Res 14: 2201–2206.
35. Hallez R, Letesson JJ, Vandenhaute J, De BX (2007) Gateway-based destination
vectors for functional analyses of bacterial ORFeomes: application to the Min
system in Brucella abortus. Appl Environ Microbiol 73: 1375–1379.
36. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like
receptor recognizes bacterial DNA. Nature 408: 740–745.
37. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting
edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to
lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol
162: 3749–3752.
38. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of
large numbers of dendritic cells from mouse bone marrow cultures supple-
mented with granulocyte/macrophage colony-stimulating factor. J Exp Med
176: 1693–1702.
39. De Chastellier C, Frehel C, Offredo C, Skamene E (1993) Implication of
phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone
marrow macrophages from genetically resistant mice. Infect Immun 61:
3775–3784.
40. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ (2000) Cutting edge:
repurification of lipopolysaccharide eliminates signaling through both human
and murine toll-like receptor 2. J Immunol 165: 618–622.
41. Garin-Bastuji B, Bowden RA, Dubray G, Limet JN (1990) Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and immunoblotting analysis of
smooth-lipopolysaccharide heterogeneity among Brucella biovars related to A
and M specificities. J Clin Microbiol 28: 2169–2174.
42. Tsai CM, Frasch CE (1982) A sensitive silver stain for detecting lipopolysac-
charides in polyacrylamide gels. Anal Biochem 119: 115–119.
43. Bowden RA, Cloeckaert A, Zygmunt MS, Bernard S, Dubray G (1995) Surface
exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella
species studied by enzyme-linked immunosorbent assay and flow cytometry.
Infect Immun 63: 3945–3952.
44. Dı´az-Aparicio E, Arago´n V, Marı´n C, Alonso B, Font M, et al. (1993)
Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica
O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and
goats. J Clin Microbiol 31: 3136–3141.
45. El Hamidi A, Tirsoaga A, Novikov A, Hussein A, Caroff M (2005)
Microextraction of bacterial lipid A: easy and rapid method for mass
spectrometric characterization. J Lipid Res 46: 1773–1778.
46. Pe´rez-Gutie´rrez C, Llobet E, Llompart CM, Reines M, Bengoechea JA (2010)
Role of lipid A acylation in Yersinia enterocolitica virulence. Infect Immun 78:
2768–2781.
47. Mancˇek-Keber M, Jerala R (2006) Structural similarity between the hydropho-
bic fluorescent probe and lipid A as a ligand of MD-2. FASEB J 20: 1836–1842.
48. Brandenburg K, Kusumoto S, Seydel U (1997) Conformational studies of
synthetic lipid A analogues and partial structures by infrared spectroscopy.
Biochim Biophys Acta 1329: 183–201.
49. Alton GG, Jones LM, Angus RD, Verger JM (1988) Techniques for the
brucellosis laboratory. Paris, France: INRA.
Brucella LPS Shields Against Innate Immunity
PLoS Pathogens | www.plospathogens.org 14 May 2012 | Volume 8 | Issue 5 | e1002675
